Merative UK
Merative UK is recorded as a service provider in 2 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 2 of 2 trials · Latest update first
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson’s Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) Gene
Sponsor Bial R&D Investments S.A.
- Start (EU)
- Latest update
- Estimated end
Operational learnings available3 trial-level findings · Read insights
- The study screened and enrolled 1,048 participants in genetic-screening Part A versus an estimate of up to 3,750 needed to randomize approximately 237 participants, and randomized 272 participants.
- The trial operated at 86 sites across 11 countries, including 44 sites in nine European countries.
- Among randomized participants, 230 (84.6%) completed dosing, and treatment exposure and compliance were high, comparable between groups, and stable throughout the study.
These findings describe the trial, not the service provider’s performance or responsibility.
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)
Sponsor Theseus Pharmaceuticals Inc.
- Start (EU)
- Not reported
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Merative UK?
The 2026-10-09 snapshot links Merative UK to 2 distinct CTIS trials. Recorded services include Electronic data capture. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Merative UK?
The most frequently recorded therapeutic areas are Neurology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Merative UK conducted?
The linked trials record locations in 8 countries, including Spain, France, Germany, Italy, Netherlands. These are trial locations, not confirmed office locations or countries where Merative UK delivered services.
What can this page tell me about Merative UK's trial experience?
Browse 2 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Merative UK. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Merative UK Limited